SECsense Logo

Bellevue Life Sciences Acquisition Corp. 8-K Filing: Key Securities Offerings Insights

$BLAC
Form 8-K
Filed on: 2025-02-13
Source
Bellevue Life Sciences Acquisition Corp. 8-K Filing: Key Securities Offerings Insights

Based on the provided section of the financial report, here are the key insights:

  1. Entity Identification:
  • The entity is Bellevue Life Sciences Acquisition Corp. with SEC CIK number 0001840425.
  1. Filing Type and Date:
  • This is an 8-K filing indicating it is a current report used to disclose major events that shareholders should know about.
  • The filing date is February 13, 2025.
  1. Securities Offered:
  • The report outlines units being offered, each consisting of:
    • One share of common stock
    • One redeemable warrant
    • One right
  • The common stock has a par value of $0.0001 per share.
  1. Warrant Details:
  • The redeemable warrants are exercisable for shares of common stock at an exercise price of $11.50 per share.
  1. Right to Receive:
  • Each unit includes a right to receive one-tenth (1/10) of one share of common stock.
  1. Stock Tickers:
  • The relevant stock tickers for these securities are:
    • BLACU for the units
    • BLAC for common stock
    • BLACW for redeemable warrants
    • BLACR for rights
  1. Location and Contact Information:
  • The company is located at 10900 NE 4th Street, Suite 2300, Bellevue, WA 98004 with a contact number of 425-635-7700.
  1. Units and Measures:
  • The report uses multiple units of measurement including USD for currency and shares for equity.

This information provides a snapshot of the company's current financial activity concerning securities offerings and outlines the structure of the units being offered, which may be of interest to potential investors and analysts.